- Home
- AMBI vs AQST Comparison
AMBI vs AQST Comparison
Compare AMBI & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBI
- AQST
- Stock Information
- Founded
- AMBI 1995
- AQST 2004
- Country
- AMBI Brazil
- AQST United States
- Employees
- AMBI N/A
- AQST N/A
- Industry
- AMBI Environmental Services
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- AMBI Industrials
- AQST Health Care
- Exchange
- AMBI Nasdaq
- AQST Nasdaq
- Market Cap
- AMBI 242.5M
- AQST 254.1M
- IPO Year
- AMBI N/A
- AQST 2018
- Fundamental
- Price
- AMBI $4.47
- AQST $2.79
- Analyst Decision
- AMBI
- AQST Strong Buy
- Analyst Count
- AMBI 0
- AQST 5
- Target Price
- AMBI N/A
- AQST $11.40
- AVG Volume (30 Days)
- AMBI 5.7K
- AQST 939.1K
- Earning Date
- AMBI 01-01-0001
- AQST 05-12-2025
- Dividend Yield
- AMBI N/A
- AQST N/A
- EPS Growth
- AMBI 250.01
- AQST N/A
- EPS
- AMBI 0.16
- AQST N/A
- Revenue
- AMBI $582,477,596.00
- AQST $57,561,000.00
- Revenue This Year
- AMBI N/A
- AQST N/A
- Revenue Next Year
- AMBI N/A
- AQST $39.51
- P/E Ratio
- AMBI $26.97
- AQST N/A
- Revenue Growth
- AMBI 27.80
- AQST 13.79
- 52 Week Low
- AMBI $3.07
- AQST $2.20
- 52 Week High
- AMBI $8.20
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- AMBI 50.91
- AQST 49.93
- Support Level
- AMBI $4.02
- AQST $2.59
- Resistance Level
- AMBI $4.66
- AQST $3.05
- Average True Range (ATR)
- AMBI 0.23
- AQST 0.16
- MACD
- AMBI 0.02
- AQST 0.00
- Stochastic Oscillator
- AMBI 65.22
- AQST 43.57
About AMBI Ambipar Emergency Response
Ambipar Emergency Response is a environmental, emergency response and industrial field service provider in Brazil with presence in 16 countries in Latin America, North America, Europe, Africa and Antarctica. The company provides customers with a full suite of environmental services organized around prevention, training and emergency response on all transportation modes. The portfolio includes a broad variety of services such as environmental remediation, industrial field services, industrial cleaning of chemical and non-chemical products and of hazardous and non-hazardous waste, consulting services focused on accident prevention and environmental licensing.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.